102 related articles for article (PubMed ID: 103573)
1. k Chain variable regions from three galactan binding myeloma proteins.
Rao DN; Rudikoff S; Potter M
Biochemistry; 1978 Dec; 17(25):5555-9. PubMed ID: 103573
[TBL] [Abstract][Full Text] [Related]
2. Structural evidence for independent joining region gene in immunoglobulin heavy chains from anti-galactan myeloma proteins and its potential role in generating diversity in complementarity-determining regions.
Rao DN; Rudikoff S; Krutzsch H; Potter M
Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2890-4. PubMed ID: 111245
[TBL] [Abstract][Full Text] [Related]
3. kappa-Chain restriction in anti-galactan antibodies.
Pawlita M; Potter M; Rudikoff S
J Immunol; 1982 Aug; 129(2):615-8. PubMed ID: 6806376
[TBL] [Abstract][Full Text] [Related]
4. kappa Chain joining segments and structural diversity of antibody combining sites.
Rudikoff S; Rao DN; Glaudemans CP; Potter M
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4270-4. PubMed ID: 6776525
[TBL] [Abstract][Full Text] [Related]
5. Sequence diversity within a subgroup of mouse immunoglobulin kappa chains controlled by the IgK-Ef2 locus.
Lazure C; Hum WT; Gibson DM
J Exp Med; 1981 Jul; 154(1):146-55. PubMed ID: 6788891
[TBL] [Abstract][Full Text] [Related]
6. Determination of the primary structure of a mouse IgG2a immunoglobulin. Amino-acid sequence of the light chain.
Schiff C; Fougereau M
Eur J Biochem; 1975 Nov; 59(2):525-37. PubMed ID: 812696
[TBL] [Abstract][Full Text] [Related]
7. kappa Chain variable region from M167, a phosphorylcholine binding myeloma protein.
Rudikoff S; Potter M
Biochemistry; 1978 Jul; 17(14):2703-7. PubMed ID: 99160
[No Abstract] [Full Text] [Related]
8. Sequence similarities among kappa IIIb chains of monoclonal human IgM kappa autoantibodies.
Pons-Estel B; Goñi F; Solomon A; Frangione B
J Exp Med; 1984 Sep; 160(3):893-904. PubMed ID: 6432934
[TBL] [Abstract][Full Text] [Related]
9. Sequence variation among heavy chains from inulin-binding myeloma proteins.
Vrana M; Rudikoff S; Potter M
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1957-61. PubMed ID: 417344
[TBL] [Abstract][Full Text] [Related]
10. Novel human light chain V kappa segment: serologic and structural analyses of the kappa III-like Bence Jones protein and IgG kappa light chain REE.
Prelli F; Tummolo D; Solomon A; Frangione B
J Immunol; 1986 Jun; 136(11):4169-73. PubMed ID: 2422275
[TBL] [Abstract][Full Text] [Related]
11. Amino acid sequence of the light chain variable region of M511, a phosphorylcholine-binding murine myeloma protein.
Apella E
Mol Immunol; 1980 Jun; 17(6):711-8. PubMed ID: 6776396
[No Abstract] [Full Text] [Related]
12. Six related protein products from a single patient with multiple myeloma.
Jemmerson R; Kaplan B; Denton MD; Anderas P; Anderson B; Margoliash E
Biochemistry; 1979 Oct; 18(21):4676-83. PubMed ID: 115490
[No Abstract] [Full Text] [Related]
13. Nucleotide sequence of the cDNAs encoding the variable region heavy and light chains of a myeloma protein specific for the terminal nonreducing end of alpha(1----6)dextran.
Borden P; Kabat EA
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2440-3. PubMed ID: 2436230
[TBL] [Abstract][Full Text] [Related]
14. Somatic diversification is required to generate the V kappa genes of MOPC 511 and MOPC 167 myeloma proteins.
Gershenfeld HK; Tsukamoto A; Weissman IL; Joho R
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7674-8. PubMed ID: 6801657
[TBL] [Abstract][Full Text] [Related]
15. Expression of equivalent clonotypes in BALB/c and A/J mice after immunization with phosphorylcholine.
Rudikoff S; Claflin JL
J Exp Med; 1976 Nov; 144(5):1294-304. PubMed ID: 62819
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of anti-framework antibodies to the kappa-chain variable region (V kappa) of mouse immunoglobulins.
Ben-Neriah Y; Lonai P; Givol D
J Immunol; 1980 Feb; 124(2):691-5. PubMed ID: 6766163
[No Abstract] [Full Text] [Related]
17. Amino-acid sequence of the variable region of the heavy (alpha) chain of a mouse myeloma protein with anti-hapten activity.
Francis SH; Leslie RG; Hood L; Eisen HN
Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1123-7. PubMed ID: 4524622
[TBL] [Abstract][Full Text] [Related]
18. Partial amino acid sequence of an IgA2 human immunoglobulin heavy chain.
Wolfenstein-Todel C; Frangione B; Franklin EC
Biochim Biophys Acta; 1975 Feb; 379(2):627-37. PubMed ID: 804325
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the VK4 light chain to antibody specificity for lysozyme and beta (1,6)D-galactan.
Smith-Gill SJ; Hamel PA; Klein MH; Rudikoff S; Dorrington KJ
Mol Immunol; 1986 Sep; 23(9):919-26. PubMed ID: 3097519
[TBL] [Abstract][Full Text] [Related]
20. [Rule of antibody structure. Primary structure of a human monoclonal IgAl-immunoglobulin (myeloma protein Tro). VI. Amino acid sequence of the L-chain, lambda-type, subgroup II].
Scholz R; Yang C; Hilschmann N
Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1903-18. PubMed ID: 118915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
